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Neutrophil granulocytes (or polymorphonuclear cells, PMNs) have long been considered as crude killing
machines, particularly trained to attack bacterial or fungal pathogens in wounds or infected tissues. That
perspective has fundamentally changed over the last decades, as PMNs have been shown to exert a livery
exchange between other cells of the innate and adaptive immune system. PMNs do provide major
immunomodulatory contribution during acute inﬂammation and subsequent clearance. Following sterile
inﬂammation like cerebral ischemia, PMNs are among the ﬁrst hematogenous cells attracted to the
ischemic tissue. As inﬂammation is a crucial component within stroke pathophysiology, several studies
regarding the role of PMNs following cerebral ischemia have been carried out. And indeed, recent
research suggests a direct connection between PMNs’ inﬂux and brain damage severity. This review
highlights the latest research regarding the close interconnection between PMNs and co-working cells
following cerebral ischemia. We describe how PMNs are attracted to the site of injury and their tasks
within the inﬂamed brain tissue and the periphery. We further report of new ﬁndings regarding the
interaction of PMNs with resident microglia, immigrating macrophages and T cells after stroke. Finally,
we discuss recent research results from experimental studies in the context with current clinical trials
and point out potential new therapeutic applications that could emerge from this new knowledge on the
action and interaction of PMNs following cerebral ischemia.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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For a long time, neutrophil granulocytes or polymorphonuclear
neutrophils (PMN) were widely seen as innate immune systems'
crude and aggressive hitmen, less sophisticated than monocytes,
macrophages or T cells. However, current research suggests that
this assumption takes only a narrow bandwidth of PMNs skills into
account. Actually, neutrophil granulocytes are, in their function as
ﬁrst defence wave, the ﬁrst cell population to arrive at the site of
microbial invasion with the task to eliminate the intruders. To
accomplish this, PMNs are equipped with impressive and various
armouries of biological weapons. These include reactive oxygen
species (ROS; Weston et al., 2006), protease stuffed vesicles, anti-
bacterial biomolecules (Faurschou and Borregaard, 2003) and the
capacity to release net-formed chromatin as so called neutrophil
extracellular traps (NETs) for the capture of extracellular pathogens
(Ruhnau et al., 2014). However, all of these armaments work efﬁ-
ciently on most live material including the host's structures, mak-
ing the PMN a dangerous cell. Therefore, PMNs' action has to be
precisely adjusted in order to avoid severe collateral damage during
inﬂammation initiation, maintenance and clearance back to tissue
homeostasis. Therefore and unsurprisingly, PMNs action is
embedded within a ﬁnely orchestrated cellular collaboration, be it
during the clearance of an infected wound or fungal infestation.
Besides of the classic “wound care”, the need for an outbalanced
immune cell reaction also applies to any sterile inﬂammation like
ischemic stroke. Following cerebral ischemia, PMNs are the ﬁrst
hematogenous cells to arrive at the site of inﬂammation and are
said to contribute to further blood-brain barrier (BBB) damage by
the release of proteolytic enzymes and oxygen radicals (Matsuo
et al., 1994; Pelus et al., 2004). However, recent research indicates
a signiﬁcant inﬂuence of PMNs on the regulation and orchestration
of the post ischemic inﬂammatory response and that PMNs have a
prominent role as effector cells in both, innate and adaptive im-
mune regulation after stroke.2. How to enter the ischemic brain and what to do as
neutrophil granulocyte
Cerebral oxygen and nutrient deprivation results in neuronal
damage, release of cytokines, chemokines and danger molecules,
endothelial presentation of adhesion molecules, subsequent
breakdown of the blood-brain barrier, glial activation and inﬂux of
a variety of hematogenous immune cells (Schilling et al., 2003,
2009; Gelderblom et al., 2009; Schuette-Nuetgen et al., 2012).
These include, next to PMNs, monocytes, macrophages, T-cells and
dendritic cells. Themain task of this cell collaboration is to clear the
debris and ﬁnally support the tissue restoring its pre-inﬂammatory
state. Particularly the release of damage-associated molecular
pattern molecules (DAMPs) like DNA, RNA, HMGB1, ATP, peroxir-
edoxin proteins (Shichita et al., 2012) by indigent and dying cells
lead to a prominent inﬂammatory reaction via activation of e.g. toll-
like receptors. This inﬂammation-like process, involving a plethora
of cell types, is orchestrated by the release of chemokines like TNF-
a, IL-6, IL-1b and the chemokine-like factor 1 (CKLF1, Kong et al.,
2014) with subsequent activation of brain glia, platelets and
vascular endothelial cells within the affected tissue (Fig. 1a and b).Please cite this article in press as: Strecker, J.-K., et al., Neutrophil granu
Neurochemistry International (2016), http://dx.doi.org/10.1016/j.neuint.2Endothelial activation and presentation of adhesion molecules on
the luminal vessel wall results in the start of a chemokine-driven
inﬁltration of hematogenous cells. The immigration of attracted
PMNs is divided into four subsequent phases namely chemo-
attraction, rolling adhesion, tight adhesion and diapedesis/migra-
tion, making the PMN ﬁnally crossing the blood-brain barrier into
the inﬂamed tissue (Fig. 1c). Known proteins involved in PMN
attraction are Selectins, ICAM-1, VCAM-1, LFA-1 and Mac-1
(reviewed in Frijns and Kappelle, 2002). Neumann et al. (2014)
showed in their recent work, that the very late antigen-4 (VLA-4
or integrin a4b1) is furthermore essential for the PMN inﬁltration
through the BBB after cerebral ischemia. They could verify their
ﬁnding by antibody-mediated blocking of VLA-4, which resulted in
reduced vessel-attached PMNs and altered PMN/endothel interac-
tion. PMNs stayed in slow rolling-status and diapedesis and
migration was limited. It is worth mentioning that the temporo-
spatial location of PMNs during and after immigration has been
controversially discussed lately. In a recent study, Enzmann et al.
(2013) report that after ischemia/reperfusion almost no PMNs
enter the actual brain parenchyma but rather stay attached to
luminal surfaces or within the perivascular space. Thus, Enzmann
and colleagues conclude to generally question the clinical relevance
of PMNs in stroke and that previous studies could be ﬂawed due to
e.g. antibodies not speciﬁc enough or non-confocal analysis of (too)
thin brain sections. This was surprising, as several other studies
report intra-parenchymal PMNs beyond the perivascular space af-
ter transient vessel occlusion (Ullrich et al., 2014; Neumann et al.,
2015) or even after permanent cerebral ischemia (Perez-de-Puig
et al., 2015; Fig. 1d). These publications demonstrate, using
confocal or two-photon intravital microscopy, that PMNs indeed
enter the brain parenchyma and can be found beyond vascular
structures like basement membrane layers. Next to the plain
neuronal loss, a further cause for post-ischemic damage is the
breakdown of the blood-brain barriers’ integrity. It has been pro-
posed that cerebral ischemia induced loss of BBB-integrity is
actually proceeding in several phases (Shi et al., 2016). The early
phase, characterized by endothelial actin-stress ﬁbre formation and
endothelial cell contraction is accompanied by disassembling of
tight- and adherens junction proteins. This in turn results in
enhanced susceptibility of basement membrane and BBBe com-
ponents to degradation by MMP-9, particularly secreted by PMNs,
leading to irreversible damage to the neurovascular unit (Fig. 1e).
Next to their capability to release proteinases and reactive oxygen,
PMNs are also known to trap e.g. bacteria in projected extracellular
decondensed chromatin. These structures, consisting of DNA, his-
tones and enzymes have been termed neutrophil extracellular traps
(NETs) (Wang et al., 2009). This formation of NETs (or NETosis) is
accompanied by pronounced nuclear histone citrullination, which
has been recently used as marker to demonstrate the presence of
NETosis even after cerebral ischemia (Perez-de-Puig et al., 2015).
Following permanent cerebral occlusion, intracerebral PMNs show
sporadically citrullinated histones and NETosis could be seen
within the perivascular space, the vessel lumen and the paren-
chyma. As some NETs were also seen surrounding pericytes, the
authors speculate that DNA, histones and enzymes expelled by
PMNs could further damage BBB-related structures (Fig. 1f). Addi-
tionally Perez-de-Puig and colleagues suggest that NETosis could belocytes in cerebral ischemia e Evolution from killers to key players,
016.11.006
Fig. 1. Stroke induced recruitment and action of polymorphonuclear neutrophils. a: Oxygen and nutrient deprived neurons release DAMPs which activate particularly glial toll-like
receptors leading to the activation of local micro- and astroglia. b: Glial chemokines trigger endothelial activation, which in turn present selectins and adhesion molecules on
the luminal vessel wall. c: Circulating PMNs are captured by selectins recognizing the ligand counterparts expressed by the PMNs, which are subsequently tethered to the
endothelial wall. Further contact with adhesion molecules leads to ﬁrm adhesion and rolling of the PMNs following the built up chemokine gradients. Finally, the PMNs migrate
through the endothelial wall and arrive at the site of inﬂammation within the parenchyma or perivascular space. d: Once arrived at the site of infarction, PMNs release a plethora of
anti-microbial enzymes, chemokines and reactive oxygen/nitrogen species resulting in further inﬂammation and chemoattraction/activation of adjacent immune cells. e þ f: The
release of proteases like MMP-9 is said to contribute to further damage of the blood-brain barrier, as well as PMNs undergoing NETosis close to the endothelial wall and perivascular
macrophages. Abbreviations: BBB: Blood-brain barrier; CCL-2: CC-chemokine ligand-2; CXCL-8: Chemokine (C-X-C motif) ligand-8; DAMPS: Damage-associated molecular patterns;
ESL-1: E-selectin-ligand-1; HMGB-1: High-Mobility-Group-Protein B1; ICAM-1: Intercellular Adhesion Molecule-1; IL-1b: Interleukin-1b; IL-6: Interleukin-6; LFA-1: Lymphocyte
function-associated antigen-1; MMP-8/9: Matrix metallopeptidase-8/9; MPO: Myeloperoxidase; PSGL-1: P-selectin glycoprotein ligand-1; RNS: reactive nitrogen species; ROS:
Reactive oxygen species; TNF-a: Tumor necrosis factor-a; VCAM-1: Vascular cell adhesion protein-1; VLA-4: Very Late Antigen-4.
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promote blood coagulation and thrombosis. Investigations
regarding the activation state of PMNs within patient blood after
stroke, however, showed contrary results. Matching the hypothesis
of a stroke induced overall immune-suppression, circulating PMNs
likewise displayed reduced oxidative burst and NETosis (Ruhnau
et al., 2014).3. Where do they come from?
The inﬂammatory response following cerebral ischemia is not,
as one might think, locally restricted to the brain parenchyma.
Several clinical trials showed that stroke induces a pronounced
inﬂammatory response during the acute phase within the periph-
ery, leading to increased PMN counts and pro-inﬂammatory che-
mokine levels within the circulation (Smith et al., 2004). Recently, it
has been shown that elevated counts of activated, peripheral PMNs
positively correlate with the risk of poorer outcome and higher
NIHSS score (reviewed in Mo et al., 2013). Studies in rodent stroke
models demonstrate a peripheral inﬂammatory response (with
regards to plasma IL-6 and CXCL-1 levels) peaking at 4 h after strokePlease cite this article in press as: Strecker, J.-K., et al., Neutrophil granu
Neurochemistry International (2016), http://dx.doi.org/10.1016/j.neuint.2onset and thereby preceding the brain inﬂammation peak which
takes place approximately 24 h after onset of ischemia (Chapman
et al., 2009; Fig. 2a). It is assumed that this temporo-spatial sepa-
rated chemokine gradient could indeed channel PMNs and other
leukocytes from their peripheral origins, particularly bone-marrow
and spleen, to the site of inﬂammation. Cerebral ischemia leads to
rapid (4 h after ischemia/reperfusion) phosphorylation of NFkB p65
and p38 MAPK in PMNs within the bone marrow, accompanied by
increased plasma CXCL-1 and G-CSF, resulting in PMN-recruitment
from the bone marrow (Denes et al., 2011; Fig. 2b). Interestingly,
this CXCL-1/GeCSFemediated PMN-mobilization has been shown
to be MMP-9-dependent, in turn secreted by already circulating
PMNs (Pelus et al., 2004). The spleens’ inﬂammatory response to
cerebral ischemia has actually shown to be detrimental by
contributing to exacerbated brain injury and neurodegeneration. At
an early stage after experimental stroke, a plethora of immune cells
is deployed from the spleen (Ajmo et al., 2009; Bao et al., 2010;
Zhang et al., 2013; Fig. 2c). These include T cells, monocytes, mac-
rophages, natural killer cells and PMNs and indeed, surgical
removal of the spleen has been shown to be neuroprotective in
models of ischemic stroke (Ajmo et al., 2009; Bao et al., 2010;locytes in cerebral ischemia e Evolution from killers to key players,
016.11.006
Fig. 2. Stroke induced recruitment of polymorphonuclear neutrophils from bone marrow and spleen. a: Following cerebral ischemia, plasma levels of G-CSF, CXCL-1, IL-6 as well as PMN-
secreted MMP-9 increase and attract further PMNs from the bone marrow into circulation. b: Recruitment of PMNs is preceded by phosphorylation of NFkB p65 and p38 MAPK,
activating the departing PMNs. c: Following built up chemokine gradients, splenocytes (Macrophages, Monocytes, T cells, NK cells and PMNs) are also released into circulation and
constitute a further population of pro-inﬂammatory cells entering the inﬂamed brain tissue. d: Increased splenocyte apoptosis and inhibited T cell proliferation capacity e: Cerebral
ischemia results in increased FoxP3 expression and regulatory T cell counts leading to splenic immunosuppression accompanied by reduced expression of pro-inﬂammatory signal
proteins (e.g. IFN-g, TNF-a and IL-6). Abbreviations: CXCL-1: Chemokine (C-X-C motif) ligand-1; CXCR-2: CXC chemokine receptor-2; FoxP3: Forkhead box P3; G-CSF: Granulocyte-
colony stimulating factor; IFNg: Interferon gamma; IL-6: Interleukin-6; MAPK: Mitogen-activated protein kinase; MMP-9: Matrix metallopeptidase-9; NF-kB: Nuclear factor kappa-
light-chain-enhancer of activated B cells; NK cells: Natural killer cells; TNF-a: Tumor necrosis factor-a.
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tion of T cells, macrophages and PMNs accompanied with dimin-
ished IL-1b and TNF-a (Zhang et al., 2013). A further interesting
observation is that the spleen, as a consequence of cerebral
ischemia, shrinks. This loss of spleen mass could be particularly
assigned to immune cell deployment but also splenocyte apoptosis
(Offner et al., 2006; Bao et al., 2010, Fig. 2c and d), accompanied by
increased regulatory T cell counts and reduced TNF-a, IFN-g and IL-
6 expression, suggesting peripheral immunosuppression (Fig. 2e). A
recent clinical study conﬁrmed that splenic atrophy also occurs in
patients suffering stroke (Sahota et al., 2013).4. Of invaders and sentinels: polymorphonuclear neutrophils
and microglia
Microglia, the CNS0 resident immunocompetent cell population
with its primary duty of brain homeostasis surveillance and
maintenance, scans its environment constantly for defect neurons,
plaques and infectious agents. Following cerebral ischemia, toll-like
receptor expressing microglia becomes activated particularly by
DAMPs, changes its morphology from ramiﬁed to motile amoeboid
shape, proliferates and migrates towards the ischemic tissue toPlease cite this article in press as: Strecker, J.-K., et al., Neutrophil granu
Neurochemistry International (2016), http://dx.doi.org/10.1016/j.neuint.2perform its emergency task: phagocytosis of debris andmodulation
of the inﬂammatory response (Schilling et al., 2005; Fig. 3a and b).
During ischemia, microglia particularly secretes next to IL-1b, IL-6
and TNF-a, CCL-2, which in turn attracts and activates e.g. CCR-2-
expressing leukocytes like Ly6Cþ-monocytes, macrophages, PMNs
and brain resident macrophages (reviewed in Taylor and Sansing,
2013; Benakis et al., 2015, Fig. 3d). A recent study found that
immigrated PMNs release Proteinase-3 (PR3) within the inﬂamed
tissue, resulting in further microglial activation and additional
neuronal death (Cho et al., 2015; Fig. 3e). It has also been proposed
that PR3, secreted by PMNs, leads to an enhanced endothelial
production of ICAM-1 and CCL-2 which in turn leads to further
monocyte and macrophage attraction (Taekema-Roelvink et al.,
2001). However, microglias role during acute ischemia and subse-
quent clearance seems not strictly limited to phagocytosis and
immune cell conducting and whether microglia exerts mainly
beneﬁcial or detrimental role remains under debate to the present
day (reviewed in Huang and Feng, 2013). Current research suggests
several additional sophisticated microglial skills during inﬂamma-
tion, clearance and repair. For instance, it has been shown that
PMNs, upon crossing the blood-brain barrier are engulfed and
phagocytosed by activated microglia (Neumann et al., 2008; 2015).locytes in cerebral ischemia e Evolution from killers to key players,
016.11.006
Fig. 3. PMN-interaction with resident microglia and inﬁltrating leukocytes. a: DAMPs, released by dying neurons activate toll-like receptor expressing immune competent cells. b:
Particularly brain resident microglia becomes activated and changes its shape from a ramiﬁed resting to a proliferating and migratory amoeboid state. c: Brain resident macrophages
become activated by DAMPs and release pro-inﬂammatory and chemoattractive proteins. d: Immigrated PMNs (in cooperation with monocytes) secret a plethora of cytokines and
chemokines, leading to the activation of brain endothelial and e: Glial cells f: Activated microglia engulfs invading PMNs. And forms cytoplasmatic processes, physically shielding
endothelial leaks. g: Growth-factors secreted by invading macrophages exert anti-apoptotic effects on PMNs. h: After extended survival, PMNs get cleared by resident and
immigrated phagocytes. i: Activated microglia physically shielding endothelial leaks. Abbreviations: CCL-2/3/4: CC-chemokine ligand-2/3/4; CCR-1/2/4: C-C chemokine receptor
type-1/2/4; CRAMP: Cathelin-related antimicrobial peptide; CXCL-1/2/3/8: Chemokine (C-X-C motif) ligand-1/2/3/8; CXCR-1/2: CXC chemokine receptor-1/2; DAMPS: Damage-
associated molecular patterns; G-CSF: Granulocyte-colony stimulating factor; GM-CSF: Granulocyte-macrophage colony-stimulating factor; IL-1b: Interleukin-1b; PMN: Poly-
morphonuclear neutrophil; TNF-a: Tumor necrosis factor-a.
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protective, conceiving a microglial thwarting of PMN's action
(Denes et al., 2007; Weston et al., 2007; Fig. 3f). Furthermore, in a
model of oxygen-glucose deprived hippocampal slices, microglial
interception of PMNs resulted in a strongly reduced neuronal
damage (Neumann et al., 2008), giving further indication of a
detrimental role of PMNs during post-stroke inﬂammation. The
ﬁnding of an ischemia-induced microglia-PMN interaction has also
been shown recently using a paradigm of permanent cortical
experimental stroke (Neumann et al., 2014). By using two-photon
intravital microscopy, Neumann and colleagues showed that
PMNs are, upon entering the brain parenchyma, chased and trap-
ped bymicroglial protrusions forming net-like structures. However,
whether captured PMNs were also phagocytosed could not be
clariﬁed within this experimental setting. Interestingly, the re-
searchers were able to see microglia forming cytoplasmatic pro-
cesses shielding endothelial leaks, indicating a further beneﬁcial
microglial task within strokes pathology (Fig. 3i). Another
intriguing, even though hypothetical explanation for microglial
uptake of PMNs could originate from observations following bac-
terial infections where macrophages have been observedPlease cite this article in press as: Strecker, J.-K., et al., Neutrophil granu
Neurochemistry International (2016), http://dx.doi.org/10.1016/j.neuint.2phagocytosing both apoptotic and viable PMNs. The authors
conclude, that by ingesting PMN granules, microglia/macrophages
could enhance their otherwise limited anti-microbial skills result-
ing in a more efﬁcient clearance (reviewed in by Silva, 2010).
Nevertheless, whether these mechanisms could apply to post-
stroke microglia-PMN interaction has to be investigated in future
studies.
5. Polymorphonuclear neutrophils and macrophages: a close
cooperation
Regarding the relationship between PMNs and macrophages
one can say that these cells have, next to their similar bone marrow
precursor (Akashi et al., 2000), several traits in common. Alongside
their main task, the professional phagocytosis of pathogenic or
other unwanted material, both show similar, albeit time-shifted
kinetics towards the inﬂamed tissue and carry out various immu-
nomodulatory effects (Gelderblom et al., 2009). Additionally, both
present similar pattern recognition receptors, and thus become
activated by common danger and pathogenic signals (Akira et al.,
2001). Despite of these similarities, PMNs and macrophages havelocytes in cerebral ischemia e Evolution from killers to key players,
016.11.006
J.-K. Strecker et al. / Neurochemistry International xxx (2016) 1e106distinct features complementing and not able to replace each other,
constituting a powerful defence for the host. In consequence of
sterile inﬂammation like cerebral ischemia, monocytes and mac-
rophages enter the brain parenchyma over a time-course of several
days following a chemokine/cytokine gradient released by the
affected brain cells (Schilling et al., 2003). Once arrived microglia,
monocytes, macrophages and PMNs collaborate in subsequent
immunomodulatory activities and start to secrete a complex
network of inﬂammation-related proteins. Macrophages and PMNs
share a plethora of chemokines (CXCL-1-3, CXCL-8, CCL-2, CCL-3/4)
and receptors (CXCR-2, CXCR-1, CCR-2, CCR-1/4) (reviewed by Silva,
2010; Fig. 3d), modulating each other's activity as well as main-
taining the local inﬂammation by creating signal feedback loops.
This is especially important for a constant replacement of required
PMNs within the inﬂamed area, as activated PMNs show a short
life-span of only 24e48 h within the infarcted parenchyma. Be-
sides, this PMN-life-span is even enhanced by adjacent anti-
apoptotic macrophage signalling, as rodent PMNs usually die af-
ter 6e12 h (Yamashiro et al., 2001; Kobayashi et al., 2005). Human
PMNs have been shown to survive up to ﬁve days within circulation
(Maeda et al., 2006), but whether this time-span also applies to
activated and immigrated cells after stroke still needs to be clari-
ﬁed. Anti-apoptotic factors prolonging PMNs life-span are partic-
ularly IL-1b, TNF-a, G-CSF and GM-CSF which are secreted partially
by macrophages (reviewed by Silva, 2010; Fig. 3g). Furthermore,
activated PMNs produce IL-1b and TNF-a which in turn attracts
additional macrophages and PMNs to the affected tissue. Note-
worthy, CRAMP (cathelin-related antimicrobial peptide), a
neutrophil-derived cathelicidin released by immigrated PMNs, also
attracts pro-inﬂammatory monocytes across the endothelium into
the inﬂamed tissue (Wantha et al., 2013). However, this speciﬁc
insight has been gathered from experiments within cremaster post
capillary venules. Whether this applies to the CNS0 blood-brain
barrier has yet to be tested. When it comes to terms to restoring
tissue homeostasis, senescent PMNs have to be removed fast and
before cell lysis, as latter could be harmful for the surrounding
tissue due to possible release of proteases etc. This task is executed
by scavenging macrophages and monocytes, which clear the
battleground of apoptotic PMNs (Savill et al., 1989; Mikołajczyk
et al., 2009; Fig. 3h).
6. Neutrophil and T cell crosstalk
Following cerebral ischemia, T cells lag slightly behind PMNs
arriving at the inﬂammatory site. Nevertheless, as both cell types
share similar temporo-spatial niches adjacent to cerebral vessels, T
cell-PMN cross-talk seems likely. In a recent in-vivo study, it has
been shown that T cells and PMN interact even under non-
inﬂammatory conditions (Thewissen et al., 2011). Mice lacking
conventional T cells (so called Rag-deﬁcient mice) and “uncon-
ventional” T cells (Tcrd-deﬁcient; devoid of gd T cells) develop
smaller infarcts and show improved functional outcome following
ischemic stroke. By using a vast variety of genetically altered mice,
Kleinschnitz et al. (2010) that conventional CD3þ-T cells contribute
to damage evolvement particularly during the early phase of brain
infarction. Interestingly, T cell-mediated aggravation was still seen
in mice lacking proteins essential for classical adaptive immunity
like antigen recognition (signal 1) or co-stimulation (signal 2)
(Gelderblom et al., 2012). The authors therefore conclude that post-
ischemic inﬂammation, injury development and even long-term
regeneration are partially T cell but not antigen mediated. Further
studies have shown CD4þ-, CD8þ and gd T cell action to be detri-
mental in ischemic stroke, whereas B-cells seem to be neuro-
protective (Yilmaz et al., 2006; Shichita et al., 2009a,b; Kleinschnitz
et al., 2010; Gelderblom et al., 2012). Whether regulatory T cellPlease cite this article in press as: Strecker, J.-K., et al., Neutrophil granu
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of debate as current research draws contradictory conclusions.
Whereas one recent study concludes that Treg absence results in
undamped activation of pro-inﬂammatory cells and exacerbated
brain damage (Liesz et al., 2009), another study suggests harmful
effects exerted by Tregs. Here, DEREG mice (devoid of Tregs)
showed dramatically reduced infarcts which could be reversed by
adoptive transfer of the missing cells (Kleinschnitz et al., 2013). The
results of another recent study report beneﬁcial effects of thera-
peutic Treg application after experimental stroke: mice subjected
to intravenous injection of regulatory T cells developed smaller
infarcts and showed reduced BBB-damage due to PD-1-mediated
suppression of PMN-derived MMP-9 (Li et al., 2013; Li et al.,
2014; Fig. 4a). When it comes to PMN/T cell interplay, recent ex-
periments have shown that upon brain ischemia, IL-17A secreted by
gd T cells triggers local astroglia to produce CXCL-1, an essential
PMN-chemoattractant. And indeed, Rag-1-deﬁcient or IL-17R-
deﬁcient mice show markedly reduced numbers of immigrated
PMNs after cerebral ischemia when compared to wildtype animals.
A clear indication for a crucial role for gd T cells in PMN attraction
(Gelderblom et al., 2012, Fig. 4b). Furthermore, it has been shown
that T cell derived cytokines like Interferon-g (IFN-g) exert anti-
apoptotic effects on PMNs (Fig. 4c) and further induce IL-23
secretion in macrophages, which in turn induces IL-17A in gd T
cells (Klebanoff et al., 1992; Shichita et al., 2009a,b; Fig. 4d). Vice
versa, chemokines like IL-2, IL-4 or IL-12 secreted by PMNs have
been shown tomodulate T cell differentiation (signal three) (Tateda
et al., 2001). Furthermore, NETs released by PMNs prime T cells via
reduction of their activation threshold in vitro. NET-primed T cells
in turn secreted increased IFN-g and IL-17A, indicating T cell dif-
ferentiation towards pro-inﬂammatory phenotypes by NETosis
(Tillack et al., 2012, Fig. 4e). However, whether NET-priming of T
cells takes place in cerebral ischemia still needs to be determined.
Arginase-I, when released by (dying) PMNs depletes extracellular L-
arginine by enzymatic degradation. This in turn results in a pro-
found T cell suppression, particularly by down-regulation of the
CD3z chain prompting the T cell to stay in the G0-G1 cell cycle phase
(Munder et al., 2006; Rodriguez et al., 2007). Interestingly, this
particular PMN-triggered T cell suppression has recently even been
demonstrated in a model of experimental ischemia. The results of
this study show that stroke can be accompanied by a markedly
reduced proliferation capacity of splenic T cells and impaired IFN-g
production (Fig. 4f). As these effects sustain over 10 days post
stroke, the authors suggest a peripheral immunosuppression and T
cell hypofunction induced by MCAO (Sippel et al., 2015). Despite of
the already known splenic shrinkage during the early phase, Sippel
and colleagues observed a signiﬁcant accumulation of PMNs within
the spleen during the sub-acute phase on day 4 following MCAO.
Besides, this splenic PMN-enrichment was time-synchronized with
the organ returning to its normal size (Seifert et al., 2012; Fig. 4f).
Leukocyte aggregation within the spleen after cerebral ischemia
has recently been addressed in two studies, which suggest splenic
overload by leukocytes after therapeutically administration of bone
marrow cells in combination with growth factor G-CSF (P€osel et al.,
2014; Strecker et al., 2016).
7. From pole to pole: neutrophil phenotype switching
As the results in many different studies obtained inconclusive
results regarding the potential detrimental or beneﬁcial role of
neutrophil granulocytes in strokes pathology, it has been proposed
that PMNs are subjected to some sort of threshold effect respond-
ing to the respective inﬂammatory milieu (Easton, 2013). Recent
evidence suggests that human as well as rodent neutrophils are,
similarly to the concept of classically activated M1 and alternativelylocytes in cerebral ischemia e Evolution from killers to key players,
016.11.006
Fig. 4. T-cell and PMN interaction following cerebral ischemia: a: Regulatory T cell-mediated inhibition of MMP-9-production by PMNs via PD-1. b: Activated gd T cells secrete IL-17A
which triggers PMN-chemoattractive CXCL-1-secretion in astrocytes. c: IFN-g, expressed by T cells inducing anti-apoptotic effects in PMN and further stimulating resident microglia
and inﬁltrated macrophages. d: Macrophage secreted IL-23 stimulates IL-17A production in gd T cells and TNF-a secreted by resident microglia and macrophages stimulates as-
trocytes to produce CXCL-1, both resulting in PMN chemoattraction. e: Potential NET-induced T cell polarization towards pro-inﬂammatory phenotypes resulting in enhanced IL-17A
and IFN-g production. f: Arginase-I release by splenic PMNs results in L-Arginine shortage and downregulation of the T cell CD3z chain leading to inhibited T cell proliferation
capacity and down regulation of IFN-g. g: Subsequent to the stroke-induced splenocyte deployment into circulation, hematogenous PMNs start to accumulate within the spleen.
Abbreviations: CXCL-1: Chemokine (C-X-C motif) ligand-1; IFNg: Interferon gamma; IL-17A: Interleukin-17A; IL-23: Interleukin-23; MMP-9: Matrix metallopeptidase-9; PD-1:
Programmed cell death protein-1; TNF-a: Tumor necrosis factor-a.
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extracellular stimuli and can as well adopt a pro-inﬂammatory so
called N1 and an anti-inﬂammatory N2 phenotype (Fridlender
et al., 2009). This neutrophil plasticity could be demonstrated just
recently in a rodent stroke model (Cuartero et al., 2013). Here the
authors report that modulation of the peroxisome proliferator-
activated receptor-g (PPARg) with its ligand Rosiglitazone results
in a PMN-shift towards a more pronounced M2-like N2-phenotype
after stroke. Notably, N2-polarized PMNs were preferentially
phagocytosed by microglia/macrophages during the 48 h survey
indicating a further crucial aspect of PMNs plasticity during wound
clearance. PMNs are even able to transdifferentiate into cell hy-
brids, expressing classical PMN-marker like Ly6G, CXCR-2, 7/4 but
also marker speciﬁc for dendritic cells (DCs) namely CD11c, MHC-
class-II, CD80 and CD86 and have been shown to acquire antigen-
presenting cell properties (Geng et al., 2013). Particularly the
expression of MHC-class-II by PMN/DC-hybrids suggests an even
more intense cross-talk of PMNs and T cells. However, until the
present day, PMN/DC-hybrids have yet to be characterized in the
context of cerebral ischemia.
8. What can be done about it?
Plenty of preclinical studies characterize the role of PMNswithin
strokes pathology, thereby offering many possibilities of beneﬁcial
therapeutic intervention. Plain depletion of circulating PMNs has
been shown to reduce infarct volume, reduce BBB-disruption and
ameliorate functional outcome (Dawson et al., 1996; Kitagawa et al.,
1998; Gautier et al., 2009; Herz et al., 2015; Neumann et al., 2015).
Therapeutic interfering with endothelial cell adhesion molecules
represents another promising strategy to limit the immigration of
potential detrimental cells. Indeed, antibody-mediated blocking of
P-selectin prior to transient focal cerebral ischemia leads to reduced
infarct volume and less petechial hemorrhage in rats (Goussev
et al., 1998). Blocking of CD47, an integrin crucial for the trans-
migration of PMNs across the BBB results in reduced PMN inﬂux
combined with reduced infarct size, less brain edema, decreased
MMP-9 levels and reduced BBB-integrity loss (Jin et al., 2009).
Blocking of several other adhesion molecules like ICAM-1, CD11b orPlease cite this article in press as: Strecker, J.-K., et al., Neutrophil granu
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tional outcome (reviewed in Jickling et al., 2015). Inducing transient
occlusion in mice deﬁcient for CD18 results in reduced infarct size,
improved cerebral blood-ﬂow and decreased mortality after tran-
sient occlusion of the middle cerebral artery (Prestigiacomo et al.,
1999). However, loss of CD18 did not show any cerebroprotective
effects in a model of permanent ischemia, prompting the authors to
suggest a more pronounced impact of PMNs within reperfusion
injury. Furthermore, gene silencing of the very-late-antigen-4
(VLA-4)/vascular adhesion molecule-1 (VCAM-1) axis by in vivo
small interfering RNA injection inhibits the immigration of PMNs, T
cells and upregulation of VCAM-1 in combination with reduced
post ischemic infarct volume and neuroinﬂammation (Liesz et al.,
2011). However, blocking with anti-CD49d antibody (a4 integrin)
showed no effects regarding infarct volume, functional outcome
and post-ischemia survival (Langhauser et al., 2014). Modulation of
the circulating and inﬁltrating PMNs could also be a promising
target in stroke therapy. Several approaches to reduce immigrating
PMN numbers showed promising results such as reduced infarct
volume and improved functional outcome (Heinel et al., 1994;
Matsuo et al., 1994; Dawson et al., 1996). Blocking accumulation
of PMNs within the ischemic cerebral cortex also resulted in
reduced infarct size, neuron degeneration and improved functional
outcome (Chu et al., 2006). Considering the convincing amount of
evidence regarding the adverse role of PMNs, it is somewhat sur-
prising that potential strategies withholding PMNs from entering
the ischemic brain parenchyma showed no beneﬁcial effects in
human stroke so far (Krams et al., 2003). Indeed, clinical studies
found a relation between PMN numbers and stroke outcome
(Akopov et al., 1996). Patients with high PMN count (>8.2  109
PMNs/L) have a higher risk for stroke and furthermore, neutrophilia
indicates increased probability of poor outcome after cerebral
ischemia (Grau et al., 2004). By using diffusion-weighted MR im-
aging it has be shown that high PMN, but not lymphocyte counts,
result in increased infarct size early after cerebral ischemia (Buck
et al., 2008). Beyond that, a recent clinical trial demonstrated an
association between high neutrophil counts on admission and
increased incidence of thrombolysis associated intracerebral
hemorrhage (Maestrini et al., 2015). However, past clinical trials onlocytes in cerebral ischemia e Evolution from killers to key players,
016.11.006
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have basically failed (Enlimomab Acute Stroke Trial Investigators,
2001; Becker, 2002; Krams et al., 2003).
9. Conclusion
Considering the fact that only a limited number of patients are
eligible for thrombolysis or thrombectomy, new and innovative
strategies for stroke treatment are urgently needed. Taking into
account that both, circulating and peripheral PMNs do release
harmful enzymes, reactive oxygen and nitrogen species, modulate
the immune response, attract and activate further cells of the
innate and adaptive immune system, makes it obvious that
modulating or reducing the circulating and inﬁltrating PMNs after
cerebral ischemia bears viable therapeutic strategies and promising
possibilities. However, most results and insights into the role of
PMNs within strokes pathology are obtained from experimental
strokemodels inmouse and rat. In particular, immune cell interplay
and potential ways to manipulate latter have to be certainly vali-
dated within humans’ stroke pathology with the possibility to
develop more sophisticated strategies for aimed and effective
intervention.
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